Publications by authors named "Pedro Ballesteros"

Claim this Profile
L
Long/post-COVID in children and adolescents: symptom onset and recovery after one year based on healthcare records in Germany.
Franz Ehm, Falko Tesch, Simone Menzer, Friedrich Loser, Lars Bechmann, Pedro Ballesteros

Infection· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-viral symptoms and conditions are more frequent in COVID-19 than influenza, but not more persistent.
Falko Tesch, Franz Ehm, Friedrich Loser, Lars Bechmann, Annika Vivirito, Pedro Ballesteros

BMC Infect Dis· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large cohort study shows increased risk of developing atopic dermatitis after COVID-19 disease.
Jochen Schmitt, Franz Ehm, Annika Vivirito, Danny Wende, Manuel Batram, Pedro Ballesteros

Allergy· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incident autoimmune diseases in association with SARS-CoV-2 infection: a matched cohort study.
Falko Tesch, Franz Ehm, Annika Vivirito, Danny Wende, Manuel Batram, Pedro Ballesteros

Clin Rheumatol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Incident autoimmune diseases in association with SARS-CoV-2 infection: A matched cohort study.
Falko Tesch, Franz Ehm, Annika Vivirito, Danny Wende, Manuel Batram, Pedro Ballesteros

Clin Rheumatol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a risk score to identify patients at high risk for a severe course of COVID-19.
Josephine Jacob, Falko Tesch, Danny Wende, Manuel Batram, Friedrich Loser, Pedro Ballesteros

Z Gesundh Wiss· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-COVID-19-associated morbidity in children, adolescents, and adults: A matched cohort study including more than 157,000 individuals with COVID-19 in Germany.
Martin Roessler, Falko Tesch, Manuel Batram, Josephine Jacob, Friedrich Loser, Pedro Ballesteros

PLoS Med· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimising the impact of COVID-19 vaccination on mortality and hospitalisations using an individual additive risk measuring approach based on a risk adjustment scheme.
Danny Wende, Dagmar Hertle, Claudia Schulte, Pedro Ballesteros, Uwe Repschläger

Eur J Health Econ· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Docetaxel plus epirubicin is a highly active, well-tolerated, first-line chemotherapy for metastatic breast cancer: results of a large, multicentre phase II study.
Serafín Morales, Antonio Lorenzo, Manuel Ramos, Pedro Ballesteros, Miguel Méndez

Cancer Chemother Pharmacol· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis